Trial Profile
Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries (Thunder – Trial)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 26 Nov 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders; Peripheral arterial occlusive disorders; Restenosis
- Focus Therapeutic Use
- Acronyms THUNDER
- 03 Nov 2011 Five-year data will be presented at the 2011 Transcatheter Cardiovascular Therapeutics scientific symposium, according to a MEDRAD Interventional media release.
- 05 Nov 2010 New trial record.